Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation
According to a story from accesswire.com, the drug developer BioVie, Inc., recently announced that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to the company's investigational…